V
Verrica Pharmaceuticals Inc. (VRCA)
NCM – Real vaqt narxi. Valyuta: USD
7.15
-0.25 (-3.38%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
7.15
-0.25 (-3.38%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Verrica Pharmaceuticals Inc. dermatologiya terapevtik kompaniyasi bo'lib, Qo'shma Shtatlarda dermatologik kasalliklarni davolash uchun dori-darmonlarni ishlab chiqish va tijoratlashtirish bilan shug'ullanadi. Kompaniya kattalar va bolalardagi mollyuskni davolash, shuningdek, oddiy siğillarni davolash uchun GMP nazoratidagi kantaridin formulatsiyasini o'z ichiga olgan dori-apparat kombinatsiyasi YCANTH (VP-102) ni taklif etadi. U, shuningdek, bazal hujayrali karsinoma va boshqa dermatologik onkologik ko'rsatmalarni o'z ichiga olgan dermatologik onkologik holatlarni davolash uchun II bosqich klinik sinovda bo'lgan onkolitik peptidga asoslangan in'ektsion terapiya VP-315 ni ishlab chiqmoqda. Kompaniya Yaponiyada mollyusk va oddiy siğillarni davolash uchun mahsulot nomzodlarini ishlab chiqish va tijoratlashtirish bo'yicha Torii Pharmaceutical Co., Ltd. bilan hamkorlik va litsenziyalash shartnomasiga ega; va Lytix Biopharma AS bilan malign va prekanseroz dermatologik ko'rsatmalarda foydalanish uchun VP-315 ni ishlab chiqish va tijoratlashtirish uchun litsenziyalash shartnomasi tuzgan. Verrica Pharmaceuticals Inc. 2013 yilda tashkil etilgan va shtab-kvartirasi Pensilvaniya shtatining Vest Chester shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Bradley J. Catalone MBA, Ph.D. | Head of Drug Development |
| Dr. Jayson M. Rieger M.B.A., Ph.D. | President, CEO & Director |
| Dr. Noah L. Rosenberg M.D. | Chief Medical Officer |
| Mr. Chris Chapman | Chief Commercial Officer |
| Mr. David Zawitz | COO, Chief Legal Officer & Secretary |
| Mr. Eugene Scavola | Executive Vice President of Technical Operations |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-12 | 10-Q | vrca-20260331.htm |
| 2026-04-20 | DEFA14A | d28726ddefa14a.htm |
| 2026-03-11 | 10-K | vrca-20251231.htm |
| 2025-12-30 | 8-K | d54232d8k.htm |
| 2025-12-19 | CORRESP | filename1.htm |
| 2025-12-15 | S-3 | d94357ds3.htm |
| 2025-12-10 | D | |
| 2025-11-24 | 8-K | d692687d8k.htm |
| 2025-11-14 | 10-Q | vrca-20250930.htm |
| 2025-08-12 | 8-K | d409147d8k.htm |
| Mr. John J. Kirby CPA | Interim Chief Financial Officer |